Elena G. Hughes

Afirma Xpression Atlas Alteration Status Is Associated with Malignancy Risk in Indeterminate Thyroid Nodules.

BACKGROUND Molecular testing with the Afirma Genomic Sequencing Classifier (GSC) is commonly used to refine the diagnosis of thyroid nodules with indeterminate cytology. The Afirma Xpression Atlas (XA) is a whole-transcriptome RNA-sequencing platform that reports expressed alterations in GSC-suspicious nodules. The cli...